Detalhe da pesquisa
1.
Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinoma.
Cancer Immunol Immunother
; 68(2): 319-329, 2019 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-30413837
2.
The effect of everolimus and low-dose cyclophosphamide on immune cell subsets in patients with metastatic renal cell carcinoma: results from a phase I clinical trial.
Cancer Immunol Immunother
; 68(3): 503-515, 2019 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-30652208
3.
Metronomic cyclophosphamide attenuates mTOR-mediated expansion of regulatory T cells, but does not impact clinical outcome in patients with metastatic renal cell cancer treated with everolimus.
Cancer Immunol Immunother
; 68(5): 787-798, 2019 May.
Artigo
Inglês
| MEDLINE | ID: mdl-30756132
4.
mTOR Inhibition Per Se Induces Nuclear Localization of FOXP3 and Conversion of Invariant NKT (iNKT) Cells into Immunosuppressive Regulatory iNKT Cells.
J Immunol
; 195(5): 2038-45, 2015 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26238486
5.
Differential effects of inhibitors of the PI3K/mTOR pathway on the expansion and functionality of regulatory T cells.
Clin Immunol
; 168: 47-54, 2016 07.
Artigo
Inglês
| MEDLINE | ID: mdl-27189717
6.
Aminobisphosphonates inhibit dendritic cell-mediated antigen-specific activation of CD1d-restricted iNKT cells.
Clin Immunol
; 158(1): 92-9, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25796193
7.
Response to Comment on "mTOR Inhibition Per Se Induces Nuclear Localization of FOXP3 and Conversion of Invariant NKT (iNKT) Cells into Immunosuppressive Regulatory iNKT Cells".
J Immunol
; 195(11): 5101-2, 2015 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26589746
8.
Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer.
BMC Cancer
; 11: 505, 2011 Nov 30.
Artigo
Inglês
| MEDLINE | ID: mdl-22129044
9.
The effects of systemic treatment with aminobisphosphonates and statins on circulating Vγ9Vδ2-T cells in patients with advanced cancer.
Immunobiology
; 223(2): 171-177, 2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29055564
10.
Immunological effects of everolimus in patients with metastatic renal cell cancer.
Int J Immunopathol Pharmacol
; 30(4): 341-352, 2017 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-28988508
11.
Evaluation of a tyrosine kinase peptide microarray for tyrosine kinase inhibitor therapy selection in cancer.
Exp Mol Med
; 48(12): e279, 2016 12 16.
Artigo
Inglês
| MEDLINE | ID: mdl-27980342
12.
Targeting Glutamine Metabolism in Breast Cancer with Aminooxyacetate.
Clin Cancer Res
; 21(14): 3263-73, 2015 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-25813021
13.
Modulation of signaling enhances the efficacy of the combination of satraplatin and erlotinib.
Curr Drug Targets
; 15(14): 1312-21, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-25382189